Home - Products - Cell Cycle/DNA Damage - AChR - Darenzepine

Darenzepine

CAS No. 84629-61-8

Darenzepine( —— )

Catalog No. M32876 CAS No. 84629-61-8

Darenzepine is a muscarinic receptor inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	344	Get Quote
5MG	427	Get Quote
10MG	599	Get Quote
25MG	861	Get Quote
50MG	1150	Get Quote
100MG	1521	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Darenzepine
Note

Research use only, not for human use.
Brief Description

Darenzepine is a muscarinic receptor inhibitor.
Description

Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
In Vitro

Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders.
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

AChR
Recptor

AChR
Research Area

——
Indication

——

Chemical Information

CAS Number

84629-61-8
Formula Weight

347.41
Molecular Formula

C21H21N3O2
Purity

>98% (HPLC)
Solubility

——
SMILES

C(\C(=O)N1CCN(C)CC1)=C/2\C=3C(C(=O)NC=4C2=CC=CC4)=CC=CC3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Biricodar dicitrate

Biricodar dicitrate (VX-710) is a potent MDR inhibitor with no anticancer activity and can be used to study prostate cancer.
tiquizium

Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.
VU 0365114

VU 0365114 is a positive allosteric modulator of mAChR M5 and increases ACh-induced calcium mobilization(EC50: 2.7 μM).

Sign In Join Free